Active ingredients
Pharmacological Group
Used in the treatment
- T14.2 Fracture of unspecified body region
- M81 Osteoporosis without pathological fracture
- M42 Spinal osteochondrosis
- M25.9 Joint disorder, unspecified
- M15-M19 Arthrosis
- K05.4 Periodontosis
- K05.3 Chronic periodontitis
- K05.2 Acute periodontitis
- M94.9 Disorder of cartilage, unspecified
- M84 Disorders of continuity of bone
- M24.9 Joint derangement, unspecified
- M24 Other specific joint derangements
- L87 Transepidermal elimination disorders
- M15 Polyarthrosis
- M15.0 Primary generalized (osteo)arthrosis
- M18 Arthrosis of first carpometacarpal joint
- M42.1 Adult osteochondrosis of spine